Homocysteinemia as a risk factor of cerebrovascular disease: Importance of age and homocysteinemia levels;A homocisteinemia como factor de risco de doença vascular cerebral: A importâneia da idade e dos níveis de homocisteinemia

Acta Medica Portuguesa

Volumn 9, Issue 1, 1996, Pages 15-20

  Palma Reis, Roberto ^a   Azinheira, Jorge ^a   Reis, Helena P ^a   Pereira, Manuel ^a   Baptista, Arlindo ^a   Crepo, Manuela ^a   Esperança Pina, Julieta ^a   Cordeiro Ferreira, Nuno ^a   Sales Luis, Armando ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; AGE; BLOOD; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MIDDLE AGED; REVIEW; RISK; RISK FACTOR; THROMBOEMBOLISM;

ADULT; AGE FACTORS; FEMALE; HOMOCYSTEINE; HUMANS; INTRACRANIAL EMBOLISM AND THROMBOSIS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS;

EID: 0029684778     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. MUDD S H, SKOVBY F, LEVY H L et al: The natural history of homocystinuria due to cystatione B-sinthase deficiency. Am J Hum Genet 1985; 37: 1-31
2. VIZY J M, COZ L P, CHADEFAUX B et al: Homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency revealed by sroke in adult siblings. Neurology 1991; 41: 1313-5
3. BRATTSTROM L: Homocysteine in vascular disease. A clinical study of homocysteine metabolism in health and in vascular disease. Thesis, University Lund, Sweden 1989
4. MCCULLY K S: Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111-128
5. MCCULLY K S. Homocysteine theory of arteriosclerosis: development and current status. Atherosclerosis Rev 1983; 11: 157-246
6. DUDMAN N P B, HICKS C WILCKEN D E L: The effects of homocysteine on the attachement of human arterial endothelial cells. J Mol Cell Card 1985; 17: R8
7. DEGROOT P G, WILLEMS C, BOERS G H et al: Endothelial cell dysfunction in homocystinuria. Eur J Clin Invest 1983; 13: 405-10
8. WEIMANN B J, KUHN H, BAUMGARTNER H R: Effect of homocysteine on cultured bovin and human endothelial cells, Experentia 1980; 36: 762
9. WALL R T, HARLAN J M, HARKER L A, STRIKER G E: Homocysteine-induced endothelial cell injury in vitro: A model for the study of vascular injury. Throm Res 1980; 18. 113-21
10. PANGANAMALA R V, KARPEN C W, MEROLA A J: Peroxide mediated effects of homocysteine on arterial prostacyclin synthesis. Prost Leuko Med 1986; 22: 349-56
11. STARKEBAUM G, HARLAN J M: Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986; 77: 1370-76
12. PREIBISCH G, KUFFNER C, ELSTNER E F: Biochemical model reactions on the prooxidative activity of homocysteine. Z Natuforsch C 1993; 48: 58-62
13. RATNOFF O D: Activation of Hageman factor by L-homocystine. Science 1968; 162: 1007-9
14. RODGERS G M, KANE W H: Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 1986; 77: 1906-16
15. PALARETI G, SALARDI S, PIAZZI S et al: Blood coagulation changes in homocystinuria: effects of pyridoxine and other specific therapy. J Pediatr 1986; 109: 1001-1006
16. RODGERS G M, CONN M T. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 1990, 75: 895-901
17. LENTZ S R, SADLER J E: Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest 1991; 88: 1906-14
18. FRANKEN D C, VREUGDENHIL A, BOERS G H et al: Familiar cerebrovascular accidents due to concomitant hyperhomocysteinemia and protein C deficiency. Stroke 1993; 24: 1599-600
19. HAJJAR K A. Homocysteine induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J Clin Invest 1993, 91: 2873-9
20. HARKER L A, ROSS R, SLICHTER S J, SCOTT C R: Homocysteine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis J Clin Invest 1976; 58: 731-41
21. MCDONALD L, BRAY C, FIELD C et al: Homocystinuria, thrombosis, and blood-platelets. Lancet 1964; 1: 745-6
22. BOERS G, SMALS A, TRIJBELS F J et al: Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985; 313: 709-715
23. BRATTSTROM L, HARDEBO J E, HULTERBERG B L: Moderate homocysteinemia. A possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 1984; 15: 1012-1016
24. CLARKE R, FITZGERALD D, O'BRIEN C et al: Hyperhomocysteinaemia: A risk factor for extracranial carotid artery atherosclerosis. Ir J Med Sci 1992; 161: 61-5
25. BRATTSTROM L, LINDGREN A, ISRAELSSON B, et al: Hiperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur J Clin Invest 1992; 22: 214-21
26. RICHARD C M, MULLER J P, FAIVRE E et al: Total plasma homocysteine determination in subjects with premature cerebral vascular disease Cin Chem 1991; 37: 126
27. BOERS, G H J, SCHOONDERWALDT H C, SHULTE B P M et al: Heterozygosity for homocystinuria: A risk factor of occlusive cerebrovascular disease? Clin Genet 1983; 24: 3001
28. BRATTSTROM L, ISRAELSSON B, HULTBERG B: Plasma homocysteine and methionine tolerance in early onset vascular disease. Haemostasis 1989; 19 Suppl 1: 35-44
29. PALMA REIS R, AZINHEIRA J, REIS H P et al: A homocisteinemia como factor de risco de doença cerebrovascular precoce. Acta Médica Portuguesa 1994
30. VERHOEF P, HENNEKENS C H, MALINOW et al: A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stoke 1994; 25: 1924-30
31. LEVENE C I, MURRAY J C: The etiological role of maternal vitamin B 6 deficiency in the development of atherosclerosis. Lancet 1977; 1: 628-9
32. MILLER J W, RIBAYA-MERCADO J D, RUSSELL R M et al: Effect of vitamin B-6 deficiency on fasting homocysteine concentrations. Am J Clin Nutr 1992; 55: 1154-60.
33. SWIFT M E, SHULTZ T D: Relationship of vitamins B 6 and B 12 to homocysteine levels: risk for coronary heart disease. Nutr Rep Int 1986; 34: 1-14
34. BRATTSTROM L, ISRAELSSON B, LINDGARDE F, HULTBERG B: Higher total plasma homocysteine level in vitamin B12 deficiency than in heterozigoty for homocystinuria due to cystathionine B-Synthase deficiency. Metabolism 1988; 37: 175-78
35. STABLER S P, MARCELL P D, PODELL E R et al: Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography - mass spectrometry. J Clin Invest 1988; 81: 466-74
36. KANG S S, WONG P W K, NORUSIS M: Homocysteinemia due to folate deficiency. Metabolism 1987; 36: 458-62
37. LEWIS C A, PANCHARUNITI N, SAUBERLICH H E: Plasma folate adequacy as determined by homocysteine level. Ann N Y Acad Sci 1992; 669: 360-62
38. HULTELBERG B, AGARDH E, ANDERSON A et al. Increased levels of plasma homocysteine are associated with nephropathy, but not with severe retinopathy in type 1 diabetes mellitus. Scand J Clin Lab Invest 1991; 51: 277-82
39. CHAUVEAU P, CHADEFAUX B, COUDE M et al. Hyperhomocisteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int Suppl 1993; 41: S72-7
40. HOROWITZ J H, RYPINS E B, HENDERSON J M et al. Evidence for impairment of transsulfuration pathway in cirrhosis. Gastroenterol 1981; 81: 668-75
41. CHADEFAUX B, COUDE M, HAMET M et al. Dosage radioisotopique de la L-homocysteine totale dans le plasma et l'urine: application à des dosages en serie. Ann Biol Clin 1990; 48: 33-36
42. PALMA REIS R: Homocisteinemia e doença vascular. Estudo epidemiológico e clínico. Tese de doutoramento apresentada à Faculdade de Ciências Médicas da Universidade Nova de Lisboa 1994, pag 81-2.
43. CLARKE R, DALY L, ROBINSON K et al: Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991, 324: 1149-55